| scholarly article | Q13442814 |
| P50 | author | Hemalatha Jayapalan | Q91632318 |
| P2093 | author name string | Yang Zhao | |
| Abayomi Ogundele | |||
| Darrell E White | |||
| Pattabhi Machiraju | |||
| Ramu Periyasamy | |||
| P2860 | cites work | Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis | Q28073073 |
| The pathophysiology, diagnosis, and treatment of dry eye disease | Q28083825 | ||
| The association of sleep quality with dry eye disease: the Osaka study | Q28601496 | ||
| Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study | Q30826797 | ||
| Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis | Q34144866 | ||
| Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years | Q34443357 | ||
| Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study | Q35572113 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study | Q36877000 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older | Q38680274 | ||
| TFOS DEWS II Introduction. | Q39453315 | ||
| TFOS DEWS II Management and Therapy Report | Q39453364 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Ocular Surface and Tear Film Changes in Older Women Working with Computers | Q42179004 | ||
| Visual problems in young adults due to computer use. | Q44679361 | ||
| Dry eye disease and work productivity loss in visual display users: the Osaka study | Q45191438 | ||
| Assessment of vision-related quality of life in dry eye patients. | Q47335465 | ||
| Update in Current Diagnostics and Therapeutics of Dry Eye Disease. | Q47424328 | ||
| Dry eye symptoms align more closely to non-ocular conditions than to tear film parameters | Q48048316 | ||
| Research Questions and Outcomes Prioritized by Patients With Dry Eye | Q57169068 | ||
| Dry Eye Syndrome Preferred Practice Pattern® | Q58119869 | ||
| Digital eye strain: prevalence, measurement and amelioration | Q60529880 | ||
| A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers | Q64071011 | ||
| Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity | Q64106425 | ||
| Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys | Q79526746 | ||
| Work productivity loss in patients with dry eye disease: an online survey | Q83645366 | ||
| Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease | Q90931447 | ||
| Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease | Q90972349 | ||
| Ocular and visual discomfort associated with smartphones, tablets and computers: what we do and do not know | Q91134825 | ||
| A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease | Q92970826 | ||
| The impact of dry eye disease treatment on patient satisfaction and quality of life: A review | Q93007707 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 875-883 | |
| P577 | publication date | 2020-03-19 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease | |
| P478 | volume | 14 |
Search more.